Global Bioenergies Hits Bio-Isobutene Milestone in Deal with U.S. -Based Industrialist

摘要

French industrial-biotechnology outfit and bio-based light-olefin developer Global Bioenergies announced October 28 that it reached a major milestone in a license option signed in 2010 with an undisclosed Fortune 500 U.S.-based “industrialist.” “According to the terms of the agreement, a license option was granted to the industrialist for a maximum of three years. If, during these three years, a specific technical milestone in the development of the isobutene program was hit by Global Bioenergies, the industrialist could trigger entering into an exclusive negotiation period for a followon contract on a specific application of Global Bioenergies’ bio-isobutene process,” according to a statement issued by Global Bioenergies.